| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/12/2004 | WO2004013309A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2004013308A2 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | WO2004013306A2 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | WO2004013304A2 Sugar and lipid metabolism regulators in plants iv |
| 02/12/2004 | WO2004013301A2 Seed-associated promoter sequences |
| 02/12/2004 | WO2004013299A2 Methods for the production of cells and mammals with desired genetic modifications |
| 02/12/2004 | WO2004013296A2 Cellular electromanipulation waveforms |
| 02/12/2004 | WO2004013295A2 Plant rna binding protein, encoding nucleic acids, and methods of use |
| 02/12/2004 | WO2004013290A2 Compositions and methods for molecular biology |
| 02/12/2004 | WO2004013288A2 Methods and kits for synthesis of sirna expression cassettes |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013280A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING |
| 02/12/2004 | WO2004013278A2 Expression vectors |
| 02/12/2004 | WO2004013276A2 Novel tricistronic vectors and uses therefor |
| 02/12/2004 | WO2004013274A2 Ghrelin binding nucleic acids |
| 02/12/2004 | WO2004013180A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | WO2004013175A1 SYNTHETIC GENE CODING FOR HUMAN GRANULOCYTE-COLONY STIMULATING FACTOR FOR THE EXPRESSION IN E. coli |
| 02/12/2004 | WO2004013174A1 Use of disease-associated gene |
| 02/12/2004 | WO2004013173A1 Novel potassium-dependent sodium-calcium exchanger |
| 02/12/2004 | WO2004013169A1 Corn root preferential promoters and uses thereof |
| 02/12/2004 | WO2004013168A2 Protein containing a burp domain |
| 02/12/2004 | WO2004013160A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | WO2004013155A2 Stabilisation of nucleic acids |
| 02/12/2004 | WO2004013151A2 Campylobacter glycans and glycopeptides |
| 02/12/2004 | WO2004013092A2 Beta-alanine n-methyltransferase |
| 02/12/2004 | WO2004013070A2 Multi-step synthesis of templated molecules |
| 02/12/2004 | WO2004012887A2 Rotatable cutting tool |
| 02/12/2004 | WO2004012851A2 Device for fast vibration of tubes containing samples |
| 02/12/2004 | WO2004012683A2 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | WO2004012669A2 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 02/12/2004 | WO2004012658A2 Method and device for protein delivery into cells |
| 02/12/2004 | WO2004012585A2 Electrophysiology assay methods |
| 02/12/2004 | WO2004012574A2 Negative selections assays, and compositions thereof |
| 02/12/2004 | WO2004012504A1 Miglur5 metabotropic glutamate receptor gene disruptions, and com positions and methods related thereto |
| 02/12/2004 | WO2004012499A2 Method of selecting cells for somatic cell nuclear transfer |
| 02/12/2004 | WO2003102238A3 Direct pcr quantification |
| 02/12/2004 | WO2003102232A3 Amplification of ribonucleic acids |
| 02/12/2004 | WO2003102152A3 Methods and materials for the production of lactic acid in yeast |
| 02/12/2004 | WO2003100061A3 Three finger toxin fold proteins |
| 02/12/2004 | WO2003097812A3 Transgenic ungulates capable of human antibody production |
| 02/12/2004 | WO2003095608A3 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 02/12/2004 | WO2003094963A3 Methylated immunostimulatory oligonucleotides and methods of using the same |
| 02/12/2004 | WO2003093316A3 Immunoglobulin-domain containing cell surface recognition molecules |
| 02/12/2004 | WO2003093307A8 Mycobacterial antigens and uses thereof |
| 02/12/2004 | WO2003091414A3 Adipocyte complement related protein zacrp8 |
| 02/12/2004 | WO2003089617A3 Methods for increasing homologous recombination of a nucleic acid sequence |
| 02/12/2004 | WO2003089587A3 Method to enhance homologous recombination |
| 02/12/2004 | WO2003089454A3 Unnatural amino acid containing display libraries |
| 02/12/2004 | WO2003087832A3 Diagnosis of carcinoma using raigi polypeptides |
| 02/12/2004 | WO2003083053A3 Constructing very long dna sequences from synthetic dna molecules |
| 02/12/2004 | WO2003080802A3 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 02/12/2004 | WO2003079766A3 Generation of plants with altered oil content |
| 02/12/2004 | WO2003078639A3 Transgenic plants expressing enzymes involved in fatty acid biosynthesis |
| 02/12/2004 | WO2003077648A3 Methods for the identification of herbicides and the modulation of plant growth |
| 02/12/2004 | WO2003076657A3 Method for identifying animals for milk production qualities by analyzing the polymorphism of the pit-1 and kappa-casein genes |
| 02/12/2004 | WO2003076583A3 Genetically engineered phage and the use of genetically engineered phage to deliver nucleic acid to bacteria |
| 02/12/2004 | WO2003076566A3 Enzymatic ligation-based identification of nucleotide sequences |
| 02/12/2004 | WO2003072789A3 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 02/12/2004 | WO2003072014A3 Minicell compositions and methods |
| 02/12/2004 | WO2003072012A3 Oral dna composition for hepatitis b virus chronic infection |
| 02/12/2004 | WO2003070968A3 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/12/2004 | WO2003070769A3 Organic compounds having anti-angiogenic activity |
| 02/12/2004 | WO2003070171A9 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 02/12/2004 | WO2003070160A3 Antisense modulation of protein expression |
| 02/12/2004 | WO2003068923A9 Signal for packaging of influenza virus vectors |
| 02/12/2004 | WO2003066869A8 Lmt tumor suppressor gene |
| 02/12/2004 | WO2003064463B1 Pluripotency determining factors and uses thereof |
| 02/12/2004 | WO2003064453A3 Trojan inhibitors, method for the production and use thereof |
| 02/12/2004 | WO2003062467A3 Tissue rejection |
| 02/12/2004 | WO2003062434B1 Transgenic tea plants obtained through microprojectile bombardment of leaf explants |
| 02/12/2004 | WO2003060142A3 Compositions and methods for controlled release |
| 02/12/2004 | WO2003060080A3 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 02/12/2004 | WO2003060066A3 Nucleic acid delivery and expression |
| 02/12/2004 | WO2003056022B1 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 02/12/2004 | WO2003054516A3 Devices and methods for isolating and detecting specific substances in complex matrices |
| 02/12/2004 | WO2003054234A9 Pcr based high throughput polypeptide screening |
| 02/12/2004 | WO2003050301A3 Susceptibility locus for schizophrenia |
| 02/12/2004 | WO2003050250A3 Chondrocyte precursors derived from human embryonic stem cells |
| 02/12/2004 | WO2003050249A3 Islet cells from human embryonic stem cells |
| 02/12/2004 | WO2003049723A3 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 02/12/2004 | WO2003047684A3 Method for intracellular modifications within living cells using pulsed electric fields |
| 02/12/2004 | WO2003046123A3 Mutated gene from corynebacterium glutamicum |
| 02/12/2004 | WO2003044203A3 Homologous recombination vector, preparations and uses |
| 02/12/2004 | WO2003044167A3 Antisense modulation of human fxr expression |
| 02/12/2004 | WO2003043411A3 Manipulation of the phenolic acid content and digestibility of plant cell walls |
| 02/12/2004 | WO2003042408A3 Sequence variants of the human growth hormone gene and methods for detection |
| 02/12/2004 | WO2003039346A3 Diagnostics and therapeutics for ocular abnormalities |
| 02/12/2004 | WO2003038130A3 Therapeutics and diagnostics for disorders of erythropoiesis |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2003033670A3 Method for preparation of single chain antibodies |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2003031650A3 Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease |
| 02/12/2004 | WO2003031589A8 Peptides and related compounds having thrombopoietic activity |
| 02/12/2004 | WO2003029416A3 Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof |
| 02/12/2004 | WO2003027276A3 Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia |
| 02/12/2004 | WO2003027227A3 Usp-3like deubiquitinating enzyme gene disruptions, compositions and methods related thereto |
| 02/12/2004 | WO2003026390A3 Plant reproduction polynucleotides and methods of use |
| 02/12/2004 | WO2003025202A3 Engineered templates and their use in single primer amplification |
| 02/12/2004 | WO2003025010A3 Human delta-n p73 molecules and uses thereof |
| 02/12/2004 | WO2003022225A3 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |